Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings

CompletedOBSERVATIONAL
Enrollment

926

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Psoriasis
Interventions
DRUG

etanercept (Enbrel®)

The patients will be treated in accordance with the requirements of the labeling of etanercept in Germany. The dosage and duration of therapy is to be determined by the physician to meet the patients' individual needs for treatment.

Trial Locations (1)

48149

Westfaelische Wilhelms-Universitaet Muenster, Zentr. f. Derm, Münster

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY